Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Testing Status of Water disinfection model (Bromodichloromethane) M970062

 

CASRN: 75-27-4

Formula: C-H-Br-Cl2

Synonyms/Common Names

  • Bromodichloromethane (Water disinfection model)
  • Water disinfection model (BDCM)

Known Uses

Solvent. Chemical intermediate. Flame retardant. Special initiative using the transgenic mouse model in methods development.

Chemical Properties

Toxicity Effects (HSDB)

Short-Term Toxicity

  • 2 weeks (Topical Application)  (C97013F)  Completed 
    • Mice: FVB/N
    • Dose: 0, 16, 32, 64, 128, OR 256 MG/KG.
  • 26 weeks (Dosed-Water)  (C97013E)  Report Review 
    • GMM-05 (NIH Number: 07-4422)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Bromodichloromethane (CASRN 75-27-4) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal, Drinking Water, and Gavage Studies) and Carcinogenicity Studies of Bromodichloromethane in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water and Gavage Studies)
    • Mice: P53 +/- (C57BL/6)
    • Dose: 0, 175, 350, OR 700 MG/L.
  • 42 weeks (Dosed-Water)  (C97013E)  Report Review 
    • GMM-05 (NIH Number: 07-4422)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Bromodichloromethane (CASRN 75-27-4) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal, Drinking Water, and Gavage Studies) and Carcinogenicity Studies of Bromodichloromethane in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water and Gavage Studies)
    • Mice: P53 +/- (C57BL/6)
    • Dose: 0, 175, 350, OR 700 MG/L.
  • 26 weeks (Topical Application)  (C97013F)  Report Review 
    • GMM-05 (NIH Number: 07-4422)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Bromodichloromethane (CASRN 75-27-4) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal, Drinking Water, and Gavage Studies) and Carcinogenicity Studies of Bromodichloromethane in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water and Gavage Studies)
    • Mice: Tg.AC (FVB/N) Hemizygous
    • Dose: 0, 64, 128, OR 256 MG/KG.
  • 39 weeks (Topical Application)  (C97013F)  Report Review 
    • GMM-05 (NIH Number: 07-4422)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Bromodichloromethane (CASRN 75-27-4) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal, Drinking Water, and Gavage Studies) and Carcinogenicity Studies of Bromodichloromethane in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water and Gavage Studies)
    • Mice: Tg.AC (FVB/N) Hemizygous
    • Dose: 0, 64, 128, OR 256 MG/KG.
  • 26 weeks (Gavage)  (C97013G)  Report Review 
    • GMM-05 (NIH Number: 07-4422)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Bromodichloromethane (CASRN 75-27-4) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal, Drinking Water, and Gavage Studies) and Carcinogenicity Studies of Bromodichloromethane in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water and Gavage Studies)
    • Mice: P53 +/- (C57BL/6)
    • Dose: 0, 25, 50, OR 100 MG/KG.
  • 41 weeks (Gavage)  (C97013G)  Report Review 
    • GMM-05 (NIH Number: 07-4422)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Bromodichloromethane (CASRN 75-27-4) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal, Drinking Water, and Gavage Studies) and Carcinogenicity Studies of Bromodichloromethane in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water and Gavage Studies)
    • Mice: P53 +/- (C57BL/6)
    • Dose: 0, 25, 50, OR 100 MG/KG.
  • 26 weeks (Dosed-Water)  (C97013J)  Report Review 
    • GMM-05 (NIH Number: 07-4422)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Bromodichloromethane (CASRN 75-27-4) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal, Drinking Water, and Gavage Studies) and Carcinogenicity Studies of Bromodichloromethane in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water and Gavage Studies)
    • Mice: Tg.AC (FVB/N) Hemizygous
    • Dose: 0, 175, 350, OR 700 MG/L.
  • 42 weeks (Dosed-Water)  (C97013J)  Report Review 
    • GMM-05 (NIH Number: 07-4422)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Bromodichloromethane (CASRN 75-27-4) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal, Drinking Water, and Gavage Studies) and Carcinogenicity Studies of Bromodichloromethane in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water and Gavage Studies)
    • Mice: Tg.AC (FVB/N) Hemizygous
    • Dose: 0, 175, 350, OR 700 MG/L.
  • 26 weeks (Gavage)  (C97013K)  Report Review 
    • GMM-05 (NIH Number: 07-4422)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Bromodichloromethane (CASRN 75-27-4) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal, Drinking Water, and Gavage Studies) and Carcinogenicity Studies of Bromodichloromethane in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water and Gavage Studies)
    • Mice: Tg.AC (FVB/N) Hemizygous
    • Dose: 0, 25, 50, OR 100 MG/KG.
  • 41 weeks (Gavage)  (C97013K)  Report Review 
    • GMM-05 (NIH Number: 07-4422)  (Peer Review Approval 09/27/2005A )
      Toxicology Studies of Bromodichloromethane (CASRN 75-27-4) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal, Drinking Water, and Gavage Studies) and Carcinogenicity Studies of Bromodichloromethane in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water and Gavage Studies)
    • Mice: Tg.AC (FVB/N) Hemizygous
    • Dose: 0, 25, 50, OR 100 MG/KG.